ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Appili Therapeutics Inc

Appili Therapeutics Inc (APLI)

0,035
0,005
(16,67%)
Fermé 21 Novembre 10:12PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,035
Prix Achat
0,03
Prix Vente
0,035
Volume échangé
90 000
0,035 Fourchette du Jour 0,035
0,025 Plage de 52 semaines 0,06
Cap du marché
Clôture Veille
0,03
Ouverture
0,035
Dernière Transaction
90000
@
0.035
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
108 760
Actions en circulation
121 266 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,96
Bénéfice par action (BPA)
-0,03
Chiffre d'affairess
6,69M
Bénéfice net
-3,78M

À propos de Appili Therapeutics Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Halifax, Nova Scotia, Can
Fondé
-
Appili Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la Toronto Stock Exchange avec le ticker APLI. Le dernier cours de clôture d'Appili Therapeutics était de $0,03. Au cours de la dernière année, les actions de Appili Therapeutics ont été négociées dans une fourchette de prix de $ 0,025 à $ 0,06.

Appili Therapeutics compte actuellement 121 266 000 actions en circulation. La capitalisation boursière d'Appili Therapeutics est de $3,64 million. Appili Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.96.

APLI Dernières nouvelles

Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Court’s approval allows transaction with Aditxt to proceed, subject to other closing conditions...

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025

Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in...

Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares

Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024 Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social...

Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target...

Appili Therapeutics Announces Results of Special Meeting of Shareholders

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI;...

Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, announced today that its acquisition target, Evofem...

Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target...

Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for...

Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A...

Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives

Aditxt, Inc. (“Aditxt” or the “Company”) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced the appointment of Sylvia Hermina to...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.0350.0350.032799720.03219933CS
4-0.01-22.22222222220.0450.0450.031559020.03413815CS
12000.0350.0450.0251087600.03286361CS
26-0.005-12.50.040.050.0251070720.03572715CS
52000.0350.060.0251276070.03715185CS
156-0.155-81.57894736840.190.190.0251701310.0667712CS
260-1.095-96.90265486731.131.60.0251657400.27304194CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SLSSolaris Resources Inc
$ 4,24
(25,44%)
1,37M
FLNTFlint Corporation
$ 0,03
(20,00%)
14k
CNECanacol Energy Ltd
$ 3,98
(16,72%)
144,87k
APLIAppili Therapeutics Inc
$ 0,035
(16,67%)
90k
KLSKelso Technologies Inc
$ 0,145
(16,00%)
40k
VRTSVertiqal Studios Corporation
$ 0,01
(-33,33%)
33,13k
APSAptose Biosciences Inc
$ 0,375
(-25,00%)
218,74k
LEVLion Electric Company
$ 0,27
(-19,40%)
1,42M
SGLDSabre Gold Mines Corp
$ 0,20
(-14,89%)
124,25k
DIAMStar Diamond Corporation
$ 0,03
(-14,29%)
28,44k
ENBEnbridge Inc
$ 59,82
(-0,22%)
10,8M
CNQCanadian Natural Resources Ltd
$ 47,21
(0,36%)
10,35M
GWOGreat West Lifeco Inc
$ 49,69
(0,26%)
6,5M
MFCManulife Financial Corporation
$ 45,01
(-1,10%)
6,47M
SUSuncor Energy Inc
$ 57,07
(-0,24%)
5,82M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock